Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

During the past decade, the number of severe infectious disease outbreaks has been alarming. Ebola in 2014, Zika in 2015, ...

This undoubtedly exists not only for Ebola, but for other infectious diseases that cause long-term sequela. For me, the one ...

A disease historically associated with malnourishment on sailing vessels may have a new, modern culprit: Bariatric surgery.

The study of immune biology in the context of infectious and inflammatory diseases is a dynamic and rapidly evolving field. Current research is focused on unravelling the complex mechanisms by which ...

SARS-CoV-2—initially thought of as an acute respiratory virus—can lead to post-COVID-19 condition (also known as long COVID), a chronic multisystemic illness that develops in some people who have been ...

Following a deficiency letter from Nasdaq received on May 7 ... a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral ...

Chronic-disease methods grew out of infectious-disease epidemiology, in which both field and laboratory methods are used. In diseases where intermediate biology was not initially observable ...

Infectious and non-infectious respiratory diseases are regarded as accelerated-age conditions in which chronic inflammation, exacerbated/dysregulated immune responses, and immunological senescence ...

MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third quarter ended September 30, ...

Arcturus Therapeutics ( (ARCT) ) has released its Q3 earnings. Here is a breakdown of the information Arcturus Therapeutics presented to its ...